June 7, 2019
IP Law Daily
The Eastern District of Virginia reversed a 2017 ruling by the Trademark Trial and Appeal Board (TTAB) dismissing the opposition to a trademark application to register the mark VAGISAN, filed by Combe, Inc., manufacturer of VAGISIL products. The court determined that consumers could indeed be confused by the similar mark VAGISAN due to the commercial strength of the VAGISIL mark, which the court established to be “famous.” Although there are 66 similar marks on the market that could have weakened the VAGISIL brand, the court found that its commercial strength was beyond enough to show it is a strong mark. In a Confusion Survey Finnegan conducted on behalf of Combe, the court found “persuasive, empirical evidence of actual confusion.” Consequently, the VAGISAN mark was ruled not registrable. Combe was represented by Finnegan.
Media Mention
Women in Business Law Americas Awards 2024: Three Finnegan Attorneys Shortlisted
April 7, 2024
Press Release
Finnegan and BMW Group Successfully Demolish Non-Practicing Entity NorthStar’s Efforts
April 3, 2024
Award/Ranking
Managing IP Americas Awards 2024: Finnegan Shortlisted for Nine Awards, Including Firm of the Year
March 12, 2024
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.